Trial Profile
A Prospective Open-Label Trial of Adalimumab in Progressive Sarcoidosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2020
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Sarcoidosis
- Focus Therapeutic Use
- 29 Jun 2016 New trial record